Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Automotive Press Releases.
Press releases published on May 19, 2025
Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value
GlobeNewswire
·
May 19, 2025
Files Investor Presentation and Issues Open Letter to Stockholders Urges Stockholders to Protect the Value of Their Investment by Voting “FOR” Each of the Company’s Highly Qualified Director Nominees LEXINGTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Keros …
Nuvini Group Announces Participation in the Sidoti Micro-Cap Investor Conference
GlobeNewswire
·
May 19, 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private B2B SaaS companies in Latin America, today announced that management will participate in the Sidoti Virtual Micro-Cap …
Critical Metals Corp Releases Further Excellent Deep High-Grade Drilling Results on Tanbreez (TREO 0.48% & HREO 27%)
GlobeNewswire
·
May 19, 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, is pleased to publish for the first time the assay results of historical deep diamond …
Fairstead and Partners Close on $120 Million Ground-Up Transformation of Historic ‘Samuel Madden Homes’ Public Housing Community in Alexandria, Virginia
GlobeNewswire
·
May 19, 2025
Leading national developer partners with the Alexandria Redevelopment and Housing Authority and The Communities Group to reimagine the Old Town Alexandria multi-block site into a 207-unit amenity-rich, mixed-use development that includes open space and a …
Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
GlobeNewswire
·
May 19, 2025
Topline data expected by year end Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in healthy subjects ATLANTA, May 19, 2025 (GLOBE …
SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology
GlobeNewswire
·
May 19, 2025
Lexicon is evaluating the safety and efficacy of sotagliflozin in patients with both obstructive and non-obstructive hypertrophic cardiomyopathy (HCM) Pivotal Phase 3 clinical trial is actively enrolling patients in 20 countries, with all sites expected to …
RedCloud Reports Full Year 2024 Results
GlobeNewswire
·
May 19, 2025
LONDON, May 19, 2025 (GLOBE NEWSWIRE) -- Trading platform company RedCloud Holdings plc (RCT) (“RedCloud” or “The Company”) today reported its financial and business results for the full year 2024. Full Year 2024 Financial Highlights include: • FY 2024 …
ViWo Starts Social Media Revolution as VCoin Presale Goes Live
GlobeNewswire
·
May 19, 2025
Kirkland, Washington, May 19, 2025 (GLOBE NEWSWIRE) -- SmarTech LLC, a USA-verified technology innovator with over 17 years of experience, announces the presale launch of ViWo, a revolutionary decentralized application (dApp). The event is live on the app' …
Doge Jones Industrial Average Partners with Indexify to Launch First Functional Memecoin Index
GlobeNewswire
·
May 19, 2025
San Juan, PR, May 19, 2025 (GLOBE NEWSWIRE) -- The Doge Jones Industrial Average (DJI) has today announced a strategic partnership with Indexify to launch the first functional meme coin index, beginning with a curated basket of the top 10 Solana memecoins. …
Vape and Go Launches Compliant, Refillable and Rechargeable Vapes in Response to United Kingdom’s Disposable Vape Ban
GlobeNewswire
·
May 19, 2025
Preston, England, May 19, 2025 (GLOBE NEWSWIRE) -- Vape and Go, the UK’s premier destination for high-quality vaping products and accessories, is happy to announce the launch of its compliant, refillable, and rechargeable alternative vapes in response to …
BIO-key and Cloud Distribution Co. Partner to Expand IAM and Biometric Security Solutions Across the Middle East
GlobeNewswire
·
May 19, 2025
WALL, N.J. and RIYADH, Saudi Arabia, May 19, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions, is pleased to announce a strategic partnership …
TopBuild Extends and Upsizes Senior Secured Credit Facilities
GlobeNewswire
·
May 19, 2025
DAYTONA BEACH, Fla., May 19, 2025 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE: BLD), a leading installer and specialty distributor of insulation and building material products to the construction industry in the United States and Canada, today announced the …
IES Holdings, Inc. Appoints Matthew Simmes to Succeed Jeffrey Gendell as Chief Executive Officer
GlobeNewswire
·
May 19, 2025
HOUSTON, May 19, 2025 (GLOBE NEWSWIRE) -- IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) announced today that Matthew Simmes, President and Chief Operating Officer, will succeed Jeffrey Gendell as Chief Executive Officer effective July 1, …
AMD Announces Agreement to Divest ZT Systems Data Center Infrastructure Manufacturing Business to Sanmina
GlobeNewswire
·
May 19, 2025
$3 billion in cash and stock, inclusive of a contingent payment of up to $450 million AMD retains ZT Systems’ rack-scale AI solutions design and customer enablement expertise to accelerate quality and time-to-deployment for cloud customers Divestiture and …
Atsena Therapeutics Announces Positive Clinical Data from Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy to Treat X-linked Retinoschisis (XLRS)
GlobeNewswire
·
May 19, 2025
First XLRS study to demonstrate efficacy and positive safety data in a Phase I/II trial Majority of patients demonstrated successful efficacy readouts across structural measurements (foveal schisis closure) and had meaningful improvement on visual function …
Reunion Neuroscience Announces Last Patient Dosed in RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
GlobeNewswire
·
May 19, 2025
-- Enrollment Completed on Schedule; Topline Results Expected Q3 2025 -- -- Company to Present Poster Reviewing RE104 Phase 1 Results at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting on May 28, 2025 -- MORRISTOWN, N.J., May 19, …
Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD)
GlobeNewswire
·
May 19, 2025
GAITHERSBURG, Md., May 19, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that it has enrolled the …
Gilat Reports First Quarter 2025 Results
GlobeNewswire
·
May 19, 2025
Revenues Increased 21% Year-over-Year with Adjusted EBITDA of $7.6 Million Reiterates Guidance for 2025 PETAH TIKVA, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite …
Gradient Denervation Technologies Announces FDA Breakthrough Designation for Pulmonary Artery Denervation System
GlobeNewswire
·
May 19, 2025
PARIS, May 19, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today the company’s pulmonary denervation system has received Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This program creates an …
Gradient Denervation Technologies annonce que son système de dénervation de l’artère pulmonaire a obtenu la désignation de dispositif innovant par la FDA
GlobeNewswire
·
May 19, 2025
PARIS, 19 mai 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies a annoncé aujourd’hui que son système de dénervation pulmonaire a reçu la désignation de dispositif innovant de la part de la Food and Drug Administration (FDA), l’Agence américaine …